# US 2012/0252043 A1 · Blood coagulation time determination method and apparatus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252043 A1
- Document ID: US20120252043A1
- Status: Published application
- Kind: A1
- Application number: 13/394,807
- Filed: 2010-09-09
- Published: 2012-10-04
- Earliest claimed: 2009-09-09
- Assignees: Andreas Hettich GmbH & Co. KG
- Inventors: Frank K. Gehring
- Web page: https://patentgrep.com/patent/US20120252043A1

## CPC

- G01N 29/036: by measuring frequency or resonance of acoustic waves
- G01N 33/86: involving blood coagulating time {or factors, or their receptors}
- G01N 2291/0256: Adsorption, desorption, surface mass change, e.g. on biosensors
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to a method for determining the coagulation time of a sample fluid containing blood components by means of a resonator whose vibration parameters are measured and then used as a basis for determining the sample fluid viscosity change, which resonator has an at least partially adhesive surface contacting said sample fluid. The invention is characterized by preincubation of said surface with a preincubation fluid containing blood components, which preincubation fluid has a known way of interacting with the coagulation system, thus resulting in anchoring sites to be formed on the adhesive areas of said surface.

## Claims

### Claim at position 1

1-23. (canceled)

### Claim 24

A method for determining the coagulation time of a sample fluid containing blood components, comprising the steps of:
preincubating a surface (10) of a resonator with a preincubation fluid (14) containing blood components, said surface of said resonator includes adhesive portions, said preincubation fluid (14) interacting with said adhesive portions of said surface in a known way forming anchoring sites on said partially adhesive portions of said surface of said resonator, and, said surface of said resonator contacting said sample fluid (12) containing blood components;
measuring a vibration parameter of said resonator; and,
determining the viscosity change of said sample fluid containing blood components based on said measured vibration parameter of said resonator.

### Claim 25 (depends on 24)

The method of claim 24 wherein said resonator is rinsed after preincubation.

### Claim 26 (depends on 24)

The method of claim 24 wherein said activated sample fluid is applied to said resonator immediately following preincubation and without any prior rinsing steps.

### Claim 27 (depends on 24)

The method of claim 24 wherein said preincubation fluid (14) is said sample fluid containing blood components (12).

### Claim 28 (depends on 24)

The method of claim 24 wherein an activator (16) is added to said sample fluid (12).

### Claim 29 (depends on 24)

The method of claim 24 wherein an activated sample fluid is applied to said preincubated resonator.

### Claim 30 (depends on 24)

The method of claim 24 wherein said measured vibration parameter pf said resonator is the resonance frequency of the resonator.

### Claim 31 (depends on 24)

The method of claim 24 wherein the coagulation time corresponds to and is measured from sample fluid activation to a local extreme value or the turning point of the course of the vibration parameter with respect to time.

### Claim 32 (depends on 28)

The method of claim 28 wherein said sample is activated using a calcium thromboplastin solution and wherein the coagulation time corresponds to the plasma thrombin time, said plasma thrombin time being Quick's time.

### Claim 33 (depends on 28)

The method of claim 28 wherein said sample is activated by means of a contact phase and phospholipids and wherein the coagulation time corresponds to the aPTT.

### Claim 34 (depends on 28)

The method of claim 28 wherein said sample is activated using kaolin or silica and wherein the coagulation time corresponds to the activated clotting time (ACT).

### Claim 35 (depends on 24)

The method of claim 24 wherein said sample fluid (12) comprises whole blood, plasma or fibrinogen.

### Claim 36 (depends on 24)

The method of claim 24 wherein following preincubation, the vibrating quartz crystal is rinsed with a buffer solution.

### Claim 37 (depends on 24)

The method of claim 24 wherein said preincubation fluid (14) is synthesized or semi-synthesized.

### Claim 38 (depends on 24)

The method of claim 24 wherein said preincubation time is at least 15 seconds.

### Claim 39

A method for determining the coagulation time of a sample fluid containing blood components, comprising the steps of:
preincubating a surface (10) of a resonator with a preincubation fluid (14) containing blood components, said surface of said resonator includes adhesive portions, said preincubation fluid (14) interacting with said adhesive portions of said surface in a known way forming anchoring sites on said partially adhesive portions of said surface of said resonator, and, said surface of said resonator contacting said sample fluid (12) containing blood components;
measuring a vibration parameter of said resonator;
determining the viscosity change of said sample fluid containing blood components based on said measured vibration parameter of said resonator;
measuring said vibration parameter beyond said coagulation time; and,
determining hyperfibrinolysis if said vibration parameter indicates an inverted course after said coagulation time.

### Claim 40

An apparatus for determining the coagulation time of a sample fluid containing blood components, comprising:
a resonator, said resonator includes a surface, said surface of said resonator includes adhesive areas (24) and non-adhesive areas (22) with respect to blood components;
preincubation fluid containing blood components, said preincubation fluid (14) forming anchoring sites on said adhesive areas of said surface of said resonator;
said surface of said resonator contacting said sample fluid (12) containing blood components;
said sample fluid containing blood components has a viscosity determined by the resonant frequency of said resonator; and,
said coagulation time occurs when said resonant frequency is at a maximum.

### Claim 41 (depends on 40)

The apparatus of claim 40 wherein said non-adhesive areas (22) of said surface of said resonator are made as protein and/or cell resistant as possible.

### Claim 42 (depends on 40)

The apparatus of claim 40 wherein said surface of said resonator is a vibrating quartz crystal surface and wherein said non-adhesive areas (22) and said adhesive areas (24) are arranged in a mosaic on said vibrating quartz crystal surface.

### Claim 43 (depends on 42)

The apparatus of claim 42 wherein said adhesive areas are formed of gold (24) and wherein said non-adhesive areas are made of polyethylene (22).

### Claim 44 (depends on 42)

The apparatus of claim 42 wherein said non-adhesive areas (22) occupy between at least 20% and maximally 90% of the total surface.

### Claim 45 (depends on 44)

The apparatus of claim 44 wherein an activator is incorporated into said surface.

### Claim 46 (depends on 45)

The apparatus of claim 45 wherein said surface includes fibrinogen.
